Io Drug Administration

News

FDA approves HIV prevention drug taken

FDA Approves First Twice-a-Year HIV Prevention Shot

Made by Gilead Sciences and sold under the name Yeztugo, the drug gives people a new way to stay protected from HIV without needing daily pills or frequent injections, The New York Times reported. “We’re on the precipice of now being able to deliver the greatest prevention option we’ve had in 44 years of this epidemic,

NBC News on MSN · 2d

FDA approves powerful HIV drug that nearly eliminated spread in clinical trials

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among people given an injection every six months.

Chicago Tribune · 2d

The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the

Zacks Investment Research on MSN1d

Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now?

Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast of a dominant position in the lucrative oncology space. Oncology ...

Targeted Oncology3d

George Shares Takeaways From IO Trials and AE Management in Pretreated RCC

During a live event, Saby George, MD, and participants discussed tolerability concerns in patients with recurrent renal cell ...

The Hill2mon

FDA to phase out some animal testing requirements, possibly replace them with AI models

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological products and drugs, instead moving toward alternative testing models such ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results